ALKERMES (8AK MU) stock market data APIs
€26.8249
-1.68(-6.3%)
as of October 28, 2025
Try our APIs with
free plan!
ALKERMES Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for 8AK.MU.
Prev. Close
26.8249
Open
25.1422
High
26.8249
Low
25.1422
52 wk Range
22.2-35
Market Cap
3 126 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ALKERMES data using free add-ons & libraries
Get ALKERMES Fundamental Data
ALKERMES Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-28
- EPS/Forecast: 0.39
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ALKERMES News
New
Alkermes: Q3 Earnings Snapshot
DUBLIN (AP) — DUBLIN (AP) — Alkermes PLC (ALKS) on Tuesday reported third-quarter net income of $82.8 million. On a per-share basis, the Dublin-based company said it had net income of 49 cents. ...
Alkermes plc Reports Third Quarter 2025 Financial Results
— Third Quarter Revenues of $394.2 Million — — GAAP Net Income of $82.8 Million and Diluted GAAP Earnings per Share of $0.49 — — Company Raises 2025 Financial Expectations — DUBLIN, Oct...
Looking at the Narrative for Avadel After the Alkermes Acquisition and Analyst Reactions
Analyst consensus for Avadel Pharmaceuticals has shifted, with the price target now set at $20. This reflects a small adjustment in line with the announced acquisition offer and the associated conting...
ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition
Alkermes plc ALKS announced that it has entered into a definitive agreement to acquire Ireland-based Avadel Pharmaceuticals AVDL in a deal valued at up to $20.00 per share in cash, representing a tota...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
